Prudential Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $186M | Buy |
7,718,545
+1,750,180
| +29% | +$45.8M | 0.2% | 85 |
|
|
2026
Q1 | $168M | Sell |
5,968,365
-517,143
| -8% | -$13.8M | 0.21% | 85 |
|
|
2025
Q4 | $161M | Sell |
6,485,508
-3,048,815
| -32% | -$76.9M | 0.2% | 97 |
|
|
2025
Q3 | $243M | Buy |
9,534,323
+2,292,521
| +32% | +$56.6M | 0.29% | 57 |
|
|
2025
Q2 | $176M | Buy |
7,241,802
+1,272,730
| +21% | +$29.7M | 0.23% | 80 |
|
|
2025
Q1 | $151M | Sell |
5,969,072
-958,465
| -14% | -$25.1M | 0.22% | 80 |
|
|
2024
Q4 | $184M | Buy |
6,927,537
+2,792,786
| +68% | +$75.8M | 0.25% | 64 |
|
|
2024
Q3 | $120M | Buy |
4,134,751
+198,301
| +5% | +$5.78M | 0.17% | 113 |
|
|
2024
Q2 | $110M | Sell |
3,936,450
-436,430
| -10% | -$12M | 0.17% | 115 |
|
|
2024
Q1 | $121M | Sell |
4,372,880
-2,031,521
| -32% | -$56.4M | 0.17% | 110 |
|
|
2023
Q4 | $186M | Sell |
6,404,401
-67,928
| -1% | -$2.05M | 0.28% | 64 |
|
|
2023
Q3 | $215M | Sell |
6,472,329
-1,307,770
| -17% | -$46.2M | 0.34% | 52 |
|
|
2023
Q2 | $285M | Sell |
7,780,099
-1,703,811
| -18% | -$66.3M | 0.41% | 40 |
|
|
2023
Q1 | $387M | Buy |
9,483,910
+379,938
| +4% | +$16.4M | 0.61% | 31 |
|
|
2022
Q4 | $466M | Sell |
9,103,972
-1,069,779
| -11% | -$51.3M | 0.79% | 19 |
|
|
2022
Q3 | $445M | Buy |
10,173,751
+2,874
| +0% | +$140K | 0.75% | 17 |
|
|
2022
Q2 | $533M | Buy |
10,170,877
+453,800
| +5% | +$23.1M | 0.85% | 15 |
|
|
2022
Q1 | $503M | Buy |
9,717,077
+127,738
| +1% | +$6.63M | 0.67% | 20 |
|
|
2021
Q4 | $566M | Buy |
9,589,339
+447,719
| +5% | +$22.2M | 0.7% | 19 |
|
|
2021
Q3 | $393M | Sell |
9,141,620
-2,357,417
| -21% | -$104M | 0.55% | 29 |
|
|
2021
Q2 | $450M | Buy |
11,499,037
+298,769
| +3% | +$11.6M | 0.62% | 22 |
|
|
2021
Q1 | $406M | Buy |
11,200,268
+1,621,098
| +17% | +$57.6M | 0.61% | 23 |
|
|
2020
Q4 | $353M | Sell |
9,579,170
-245,196
| -2% | -$8.99M | 0.59% | 26 |
|
|
2020
Q3 | $342M | Buy |
9,824,366
+2,820,266
| +40% | +$98.9M | 0.64% | 23 |
|
|
2020
Q2 | $217M | Buy |
7,004,100
+34,715
| +0.5% | +$1.18M | 0.41% | 46 |
|
|
2020
Q1 | $216M | Buy |
6,969,385
+556,699
| +9% | +$19M | 0.47% | 33 |
|
|
2019
Q4 | $238M | Buy |
6,412,686
+144,893
| +2% | +$5.16M | 0.35% | 59 |
|
|
2019
Q3 | $214M | Sell |
6,267,793
-734,842
| -10% | -$26.7M | 0.34% | 59 |
|
|
2019
Q2 | $288M | Sell |
7,002,635
-1,245,068
| -15% | -$49.4M | 0.45% | 41 |
|
|
2019
Q1 | $332M | Sell |
8,247,703
-2,869,318
| -26% | -$115M | 0.55% | 27 |
|
|
2018
Q4 | $460M | Sell |
11,117,021
-499,352
| -4% | -$20.7M | 0.81% | 21 |
|
|
2018
Q3 | $486M | Sell |
11,616,373
-259,021
| -2% | -$9.97M | 0.71% | 19 |
|
|
2018
Q2 | $409M | Sell |
11,875,394
-388,850
| -3% | -$13.3M | 0.61% | 22 |
|
|
2018
Q1 | $413M | Sell |
12,264,244
-361,733
| -3% | -$12.4M | 0.63% | 22 |
|
|
2017
Q4 | $434M | Sell |
12,625,977
-1,253,524
| -9% | -$42.7M | 0.59% | 26 |
|
|
2017
Q3 | $470M | Buy |
13,879,501
+3,236,592
| +30% | +$104M | 0.68% | 23 |
|
|
2017
Q2 | $339M | Sell |
10,642,909
-2,345,697
| -18% | -$74M | 0.5% | 33 |
|
|
2017
Q1 | $422M | Sell |
12,988,606
-2,320,276
| -15% | -$73.2M | 0.66% | 22 |
|
|
2016
Q4 | $472M | Sell |
15,308,882
-1,086,400
| -7% | -$33.2M | 0.76% | 18 |
|
|
2016
Q3 | $527M | Buy |
16,395,282
+2,125,308
| +15% | +$71.1M | 0.87% | 13 |
|
|
2016
Q2 | $477M | Buy |
14,269,974
+1,035,630
| +8% | +$33.1M | 0.8% | 16 |
|
|
2016
Q1 | $372M | Sell |
13,234,344
-3,283,516
| -20% | -$93.8M | 0.67% | 23 |
|
|
2015
Q4 | $506M | Sell |
16,517,860
-6,614
| -0% | -$208K | 0.92% | 15 |
|
|
2015
Q3 | $492M | Buy |
16,524,474
+715,825
| +5% | +$23M | 0.97% | 10 |
|
|
2015
Q2 | $503M | Sell |
15,808,649
-508,660
| -3% | -$16.6M | 0.89% | 10 |
|
|
2015
Q1 | $539M | Sell |
16,317,309
-3,091,814
| -16% | -$98.3M | 0.93% | 9 |
|
|
2014
Q4 | $574M | Buy |
19,409,123
+10,329
| +0.1% | +$296K | 1.04% | 9 |
|
|
2014
Q3 | $544M | Sell |
19,398,794
-1,367,844
| -7% | -$38.4M | 1.02% | 11 |
|
|
2014
Q2 | $585M | Buy |
20,766,638
+1,249,748
| +6% | +$35.6M | 1.03% | 9 |
|
|
2014
Q1 | $595M | Buy |
19,516,890
+1,170,153
| +6% | +$34.9M | 1.11% | 10 |
|
|
2013
Q4 | $533M | Sell |
18,346,737
-646,027
| -3% | -$18.8M | 1.06% | 10 |
|
|
2013
Q3 | $517M | Sell |
18,992,764
-982,965
| -5% | -$26.7M | 1.1% | 10 |
|
|
2013
Q2 | $531M | Buy |
+19,975,729
| New | +$552M | 1.18% | 9 |
|
Other funds holding PFE
VCM
VPM
Prudential Financial's PFE Position: Q2 2026 in Review
Prudential Financial increased its Pfizer (PFE) stake by 29% in Q2 2026, buying an estimated $45.8M and bringing the position to 7,718,545 shares worth $186M. The position accounts for 0.2% of the portfolio, ranked #85.
Prudential Financial first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $595M in Q1 2014. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Prudential Financial held 7,718,545 shares of Pfizer worth $186M as of Q2 2026.
- Prudential Financial bought 1,750,180 Pfizer shares in Q2 2026, an estimated $45.8M.
- Pfizer made up 0.2% of Prudential Financial's portfolio in Q2 2026, its #85 holding.
- Prudential Financial first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Pfizer position peaked at $595M in Q1 2014.
- 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.